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Background and Aims: The goals of this paper are: 1) to critically review and analyze the
methodology of the studies since 1990 linking stress to inflammatory bowel disease; and 2) to
make recommendations for future research in this area of research. Methods: Articles were
restricted to empirical reports in the English language with human subjects. Eleven empirical
articles were able to answer “How is psychological stress related to inflammation and/or the
expression or course of inflammatory bowel disease?” Results: Studies varied by choice of par-
ticipant groups, method for classifying disease activity, choice of design, and definition and
measurement of stress. Only half of the studies supported the hypothesis that stress affected IBD
in some way. Conclusions: Current methodological limitations in the stress and gut inflammation
research have made it difficult for us to ascertain the role of stress in inflammatory bowel
disease. Authors provide a checklist of items to consider when designing future studies.
© 2008 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.KEYWORDS
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Historically, stress has been linked to the onset and main-
tenance of gastrointestinal symptoms. Since the 1930s,
gastroenterologists and psychiatrists alike have implied
that emotional life events or experiences are contempor-
aneously linked to intestinal inflammation.1–3 However,
research in this area has been notoriously weak, with many
studies uncontrolled, due, in part, to the early misconcep-
tion that the “evidence” for this relation was so strong that
no control groups were necessary.4 In the 1960s, research
examining the interactions between psychosocial and biolo-
gical factors in Inflammatory Bowel Disease (IBD) improved
markedly with respect to scientific rigor. However, the
subjectivity with which stress was measured remained a
significant barrier to identifying the relations between stress
and inflammation5 in both Ulcerative Colitis (UC) and Crohn's
Disease (CD).
While the basic science research supporting the role of
stress in the inflammatory process in the gut is beyond the
scope of this review, current literature supports the idea that
stress has a direct role in the pathophysiology of IBD.7
Potential mediators of immune and neural-immune factors
implicated in IBD include substance P, vasoactive intestinal
protein, tumor necrosis factor, heat shock proteins, oxygen
free radicals and oxidants, and endogenous glucocorticoids.6
While animal studies of gut inflammation and factors
affecting the onset and maintenance of inflammatory
bowel disease have consistently demonstrated the role of
environmental stress in the disease process,53–55 these
findings have not directly translated into research on
human subjects. There are several methodological reasons
for this, including uniquely human research issues such as
finding a sufficient stressor, limitations of self-report, recall
bias and the role of organic disease in the human perception
of stress.
One of the main issues facing our current literature
relating stress and inflammatory bowel disease that likely
permeates other areas of psychosomatic medicine is a
comprehensive, theoretically and practically sound defini-
tion of stress upon which to rest our assumptions regarding
stress and disease. While biologists refer to factors such as
heat, cold, restraint, and inadequate food supply as sources
of stress and immunologists consider stress any stimulus that
induces activation of the Hypothalamic–Pituitary–Adrenal
(HPA) axis and sympathetic nervous system,8 social scientists
are more often concerned with people's interaction with the
environment and the resulting emotional consequences. The
paucity of studies adequately defining stress before deter-
mining its physiological effects leaves most of us feeling that
stress can be anything to anyone and that it can contribute to
just about any disease.92. Defining stress
From a social science perspective, the most rudimentary
method of defining stress stems from a “response-based”
view, such as that described by Hans Selye.10,11 From this
viewpoint, stress can be considered a physiological response
to a “stressor,” or an adverse circumstance in the environ-
ment leading to sympathetic nervous system activation,
commonly known as the “fight-or-flight response.” This re-
sponse-based approach is the most commonly adopted
definition in medical stress research. Response-based mea-
sures ask primarily about symptoms, emotions, physiologi-
cal changes and behaviors associated with a stressor. The
Perceived Stress Questionnaire12 and the Perceived Stress
Scale13 are examples of such measures. While valid and
reliable, one disadvantage of a response-based approach to
stress is that it often confounds stress with its consequence—
answers on such scales may be related to the subjective
feeling of stress after the response has already occurred.
Other definitions of stress are stressor-based14,15; in other
words, looking at various types of events and attempting to
determine which ones trigger an “adaptive effort to cope” by
the organism. Those events requiring more effort are con-
sidered more stressful. This type of view is supported by life
events checklists, such as those developed by Holmes and
Rahe,15 and assumes that certain events are more “stressful”
than others.16 One disadvantage of this definition is that it
does not account for subjective experience—for one person, a
divorce may be a relief of chronic tension in the household
and for another person a devastating loss.
The most widely adopted conceptualization of stress by
psychologists to date is the cognitive-transactional theory of
stress.17,18 From this perspective, stress is defined as “a real
or perceived imbalance between environmental demands
required for survival and an individual's capacity to adapt
to these requirements.19” Lazarus' paradigm differs from
the stimulus-based or response-based approaches described
above in that it is no longer uni-directional or context free.
Rather, stress is considered to be part of a sequential process
that includes a) antecedents, which are individual difference
variables such as one's attitudes or beliefs, history with a
stressor, or other demands; and b) mediators, which refer
to coping skills, appraisals, social support and other variables
that have immediate and direct effects on the situation. The
theory allows for a large amount of variation in an individual's
repertoire of coping resources and vulnerabilities.19 There-
fore, measurement of stress needs to take into account such
variables. While there are no good measures to date that
assess the entire context of a stressor(s), we can include
multiple measures of stress and identified mediating vari-
ables in our studies. While certainly not an exhaustive list,
some of the most commonly cited mediators of the stress
Table 1 Models of stress
Model of stress Description Examples of measures
Response-based
(Selye10)
Stress is the response to an adverse circumstance
leading to the “fight-or-flight” response
Perceived Stress Questionnaire12; Perceived
Stress Scale13
Stressor-based
(Dohrenwend and
Dohrenwend14)
Stress triggers an active effort to cope; events
requiring more coping are more stressful
Life Events Checklist15
Cognitive-
Transactional
(Lazarus and
Folkman19)
Stress is “a real or perceived imbalance between
environmental demands required for survival and an
individual's capacity to meet those requirements19
None currently available; must use measures of
mediating variables in addition to standard
stress measures
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controllability.22,23 A review of stress research and theories of
stress in health psychology can be found elsewhere.56 See
Table 1 for a summary.
While there have been some recent reviews of the lit-
erature linking stress and IBD, these reviews have focused on
either the neuro-immunological relations between stress and
inflammation57,58 or have collapsed stress into a review of
“psychological factors” that includes emotion, stress and
the effects of psychological treatments.59 While the reviews
do make excellent recommendations for future research,
their broad scope has likely limited their impact on future re-
search in this area.
The goal of this paper is to critically review and analyze
the several studies linking stress to inflammatory bowel dis-
ease and to determine factors that may be important when
designing future studies. We emphasize a cognitive-transac-
tional model of stress, which is most commonly adopted by
health psychologists, and accounts for additional factors in-
fluencing the relations between stress and disease. To pre-
vent redundancy, we have chosen to simultaneously present
our results and offer a discussion of the methodological is-
sues and questions they raise.
3. Methods
Complete searches of Medline, PubMed, PsychInfo and PsycLit
were performed using the following search terms: stress and
intestine; stress and colitis, stress and Crohn's, stress and
bowel, life events and intestinal. Articles were restricted to
empirical reports in the English languagewith human subjects.
Studies were carefully chosen for methodological soundness
and appropriateness of the main research question in our
review, namely “how is psychological stress related to in-
flammation and/or the expression or course of inflammatory
bowel disease?” Of the studies that met our search terms,
eleven were empirical reports and directly measured stress
and intestinal symptoms, therefore meeting our criteria for
review (Table 2). Studies were excluded (n=8) if they did not
directly measure stress, only speculated about the role of
stress in inflammatory bowel disease or focused primarily on
psychopathology rather than on stress.
In order to better understand how the various studies
went about determining outcome, we decided to compare
and contrast methodology in these studies and discuss ways
the methodology may have impacted the results. It becameapparent that differences existed between the groups on the
following methodological variables of interest and likely
impacted outcome: choice of participant groups, method for
classifying disease activity, choice of design (prospective,
retrospective, cross-sectional) and definition and measure-
ment of stress. Given the small sample size of articles ap-
propriate for this review and the variability in outcome
measures and design, this type of review does not lend itself
to meta-analytic techniques, although analyses of effect size
may be important and interesting at a later date.
4. Results and discussion
Of the eleven studies reviewed, six (55%) supported the hy-
pothesis that stress affects IBD in someway. Two of the studies
did not support this hypothesis, and three studies produced
inconclusive results (Table 3).
4.1. Choice of participant groups
Four of the eleven studies reviewed included patients with
Ulcerative Colitis (UC) only. In three out of four of these stud-
ies, the UC patients were in remission. One of the studies24
used a cross-sectional design, comparing patients who were
both symptomatic and asymptomatic.
Two studies used patients with symptomatic Crohn's
Disease. Five studies used a mixed group of UC and CD pa-
tients, with 3 of these studies25–27 obtaining inconclusive
results. To further complicate the picture, four out of the five
studies using a mixed group of IBD also used patients with
mixed disease status (active vs. remission). This practice of
includingmixed disease status confuses the effect that disease
may have on recall and perception of stress and weaken power
to detect differences.
Interestingly, only one study out of the eleven reviewed
used a healthy control group.27 Use of appropriate control
groups is essential for valid comparison. The use of control
groups can help to identify the effects that chronic disease
can have on symptoms and on perception of stress and its
markers. For example, irritable bowel syndrome (IBS) patients
who have chronic, relapsing GI symptoms and are known to be
influenced by stress28 would be a good comparison group
to assess the effects of chronic gastrointestinal symptoms
without any inflammation. Comparing IBD patients to other
groups of patients with inflammatory disorders with respect to
inflammation levels and stress levels would also likely help us
Table 2 Empirical studies on IBD and stress between 1990 and present
Study Population Stress measures Time Relations between
stress and disease
Riley et al.38 57 UC, remission HADS, Paykel Life Event Interview,
Daily Symptom Diary
Prospective Cohort
Study; 12 week
intervals for 48 weeks
or relapse
Stress does not influence
disease activity; seasonal
variation may
Duffy et al.25 53 UC, 77 CD,
remission
Schedule of Recent Experience CDAI Prospective; monthly
for 6 months
Inconclusive
North et al.43 24 CD, 8 UC,
mixed status
Social Readjustment Rating Scale (SRRS)
Beck Depression Inventory GI Symptom
Diary
Prospective
monitoring monthly
for 2 years
Life events do not
affect symptoms
vonWietersheim
et al.26
51 UC and 57 CD
recruited in-
hospital, and 60
controls
SRRS + 4 questions Questionnaire
constructed by authors about feelings and
specific events preceding the relapse
CDAI
Prospective; at
admission, at
discharge, every
3 months for 1 year
Inconclusive
Levenstein
et al., 1994
46 asymptomatic
UC 32
symptomatic UC
Perceived Stress Questionnaire (PSQ)
Paykel Interview for Life Experiences
State-Trait Anxiety Inventory (STAI)
Center for Epidemiological Studies-
Depression (CES-D) Rectal mucosa by
proctoscopy
Cross-sectional;
single administration
of questionnaires
Stress has some effect on
inflammation in both
asymptomatic and
symptomatic patients
Levenstein
et al.39
62 UC, remission PSQ Paykel Life Events Interview CES-D
Rectal mucosa by proctoscopy
Prospective, every
6 months over 4 years
or until relapse
Chronic stress increases
likelihood of relapse
Bitton et al.37 60 UC, remission Symptom Checklist-90 (SCL-90)
Psychiatric Epidemiology Research
Interview (PERI) Life Events Scale
Perceived Stress Scale (PSS) Flexible
sigmoidoscopy
Prospective, every
month for one year or
until relapse
# of events, rather than
perception of stress is
weakly related to relapse
Garrett et al.32 10 CD,
symptomatic
Daily Stress Inventory (DSI) Life
Experiences Survey (LES) Daily CD Diary
based on CDAI
Prospective, daily
monitoring over
28 days
Daily stress, rather than
life events seems to
influence CD symptoms
Greene et al.33 6 CD,
symptomatic 5
UC, symptomatic
DSI + coping IBD Symptom Diary Prospective, daily
monitoring for 1
week/month for
1 year
Daily stress has impact on
daily symptoms
Traue and
Kosarz52
20 CD,
symptomatic
DSI CD symptom diary Prospective, daily
monitoring for
3 months
Stress may affect
symptoms in certain
patients
Sewitch et al.27 137 CD, mixed
status 63 UC,
mixed status
SCL-90 Social Support Questionnaire
Weekly Stress Inventory PSS Harvey–
Bradshaw Dis. Index
Cross-sectional;
single administration
of questionnaires
Inconclusive
196 L. Keefer et al.to better understand the mechanism by which stress acts on
the body. For example, stress is also believed to influence the
onset and course of rheumatoid diseases, including arthritis,
lupus and fibromyalgia.29 Multiple sclerosis exacerbations have
also been shown to be linked to recent stressful life events.30
The average number of study participants in the reviewed
studies was 70(58), ranging from 10 to 200. None of the studies
reported whether they had conducted a power analysis, or
whether the study had adequate power to test their hy-
potheses. Future studies should use an adequate number of
well-defined groups of patients with IBD (UC vs. CD; active vs.
inactive) and compare the results with appropriate control
groups such as patients with chronic inflammation to control
for chronic inflammatory process and patients with chronic
gastrointestinal symptoms to control for symptoms.4.2. Classification of disease activity
Four of the eleven studies used an objective measure of
inflammation/relapse in their patients. Seven studies used
objective measures of inflammation such as unprepared flex-
ible sigmoidoscopy and, in one case, rectal biopsy specimen.24
Two of the eleven studies did not use objective measures, but
did rely on standardized measures of disease activity, such as
the Crohn's Disease Activity Index,31 (CDAI)26 or the Harvey–
Bradshaw Index.27 Unfortunately, the other 2 studies used
subjective measures of disease activity. Most often, a symp-
tom diary based on the CDAI or a similar rating scale was used.
Clearly, there are some inherent problems with using sub-
jective measurement of disease status. First, patients like-
ly perceive the frequency and severity of their symptoms
Table 3 Features of studies reviewed
Feature Number
of studies
Concludes that stress affects
disease activity in some way
6
Concludes that stress does not
affect disease activity
2
Inconclusive 3
Used a prospective design 9
Used a cross-sectional design 2
Used life events as stress measure 7
Used hassles/daily stress as stress measure 4
Used Ulcerative Colitis as model 5
Used Crohn's Disease as model 2
Used IBD as a model (both UC and CD) 4
Average follow-up period (weeks) 50.54 (60.93)
Average interval of measurement (weeks) 5.75 (7.46)
Average number of study participants 69.81 (57.76)
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between perception of stress but with respect to perception of
symptoms. Secondly, there is some evidence that inflamma-
tion in response to stress is present, even when the individual
appears to be clinically asymptomatic,24 making it imperative
to objectively measure the effects of stress. Future studies
should use validated objective measures which may include
clinical symptoms (like the CDAI),markers of the inflammatory
process (like C-reactive protein) and/or tissue inflammation/
injury (endoscopic findings, histology).
4.3. Choice of design
Nine of the eleven studies used a prospective research design,
following participants for an average of almost 1 year
[50.55 weeks (60.93)]. The average follow-up interval during
the study was 5.7 weeks (7.46), with a range of 0–24 weeks.
Two of the studies used a cross-sectional design, comparing
asymptomatic patients in remission with symptomatic pa-
tients during flare-up on a variety of stress measures. Cross-
sectional designs are probably no longer an appropriatemeth-
odology for answering questions about how stress influences
disease—we now know enough about how a disease itself can
exacerbate stress and therefore would never be able to de-
termine directionality in a cross-sectional design. For these
reasons, prospective research is more methodologically rig-
orous and the design of choice. It is important to decide upon
a standardized time frame in which to measure stress and
symptoms to ensure that our measurement of these variables
best captures the course of the disease. We were disap-
pointed to find that 5 of the 9 studies that monitored stress
and inflammation prospectively used cross-sectional ana-
lyses, comparing people who relapsed over time with those
who did not,25,26,38,39,43 again significantly limiting the types
of conclusions that can be drawn from such studies.
4.4. Definition of stress
Only one of the eleven studies reviewed operationally de-
fined “stress” before describing the choice of measurement.In that study, the authors32 simply defined stress as envi-
ronmental events. Keep in mind, however, that the lack of
good operationalized definitions is not just a problem in the
gastroenterology literature. Future studies should carefully
define stress prior to measuring its physiological effects. We
recommend that the transactional model be considered the
“gold-standard” for stress research. This model offers the
most dynamic and complete picture of the stress response,
allows for the differential effect of stress on individuals, and
addresses other variables that interact with stress that could
provide more explanatory power.
Two studies addressed these mediator variables, albeit in
a limited way. One of the studies33 reviewed included a
measure of coping. Another study included a short measure
of social support and suggested that interventions aimed at
improving support could have a favorable impact on health
and disease activity.27
4.5. Choice of stress measurement
Seven of the studies relied on the occurrence of major life
events as their measure of stress. Four of the studies relied
on the experience of “hassles” or minor annoyances as their
primary outcome measure. Only 1 of the studies used both
indices of stress. Given the complicated nature of stress, as
described above, it is likely that neither approach tomeasuring
stress fully addresses the complicated interaction between
stress and disease activity. The lack of standardized measures
results in the use of different measures in each study, mak-
ing comparison across studies difficult. For example, in the 11
studies selected for this review, the investigators used 5 dif-
ferent measures of life events and 4 different measures of
“hassles.” Therefore, conclusions drawn about the effects of
stress on the course of IBD can be influenced by the type of
measures (life events or hassles) used in these studies. In oth-
er words, the difference in the findings may represent meth-
odological flaws or may indicate that each of these methods
measures a different aspect of stress and thus provides a
clue as to the mechanism of stress on inflammation and/or
symptoms.
4.5.1. Studies that used life events as measure of stress
The majority of the standardized questionnaires that are used
to evaluate the effects of major life events on psychosocial
functioning originated in the study of psychiatric illness, such
as depression and schizophrenia.34,35 Thus, it is not surprising
thatmany of these questionnaires do not take into account the
stress of having a chronic disease and how this may contribute
to the experience of life events. For example, an exacerbation
of Crohn's disease or a scheduled surgery may result in work or
financial stress, or in some cases, loss of a job. The cyclical
nature of the disease can make it very difficult to determine
the preceding stressor (chicken or egg) as many of the
antecedents and consequences are intertwined.
The use of questionnaires that are not specific to health-
related problems could also introduce bias into the findings.
Some researchers have attempted to categorize types of
stressors (i.e. health, interpersonal, etc.) to recognize this
problem.25 While their findings have been overall inconclu-
sive, the results did seem to support a modest statistical trend
towards interpersonal stress experiencedprior toparticipation
198 L. Keefer et al.in the study and an increased risk of relapse. Further, health-
related stress experienced at follow-up was the most
significant type of stressor experienced, which reinforces the
notion of measuring the impact of the disease on stress25 and
not just the impact of stress on the disease.
Another problem inherent in relying solely on the docu-
mentation of life events as ameasureof stress is that life events
are not all made equal, and certain life events may be more
significant for some individuals than others. In other words, the
sheer number of stressors does not necessarily reflect the level
of stress in a person's life. Some have argued that once a
significant stressor has occurred, additional stressors do not
typically change symptomoutcome.36 If this is the case, studies
that report “stress” summary scores do not always allow for
adequate comparisons of groups. This may explain why there
was only aweak relation between number of events and time to
relapse in a recent study.37 Along the same lines, dividing
patients into “high” or “low” stress groups based on numeric
cut-offs (i.e. average number of stressors over 6 months) may
be problematic and result in inconclusive findings.25
Perception of stress should always be taken into account
as well. As discussed earlier, the mere occurrence of an event
does not necessarily suggest that the event was stressful.
Thus, having participants rate the impact of their stressor,
which is the procedure described in the Life Experiences
Survey37 may be beneficial. This was done in some of the re-
viewed studies.24,37–39
Further difficulty arises when one administers life events
questionnaires retrospectively. Once a person has become ill,
it is likely that theywill have biased recall of the period of time
prior to their illness,40 possibly looking for an explanation for
why they became ill. Further, altered eating, sleeping or
medication use during illness can also affect stress levels and
influence reporting.While the overall number of eventsmay or
may not remain the same, the perceived impact of them may
be heightened due to a variety of psychological factors.41
Finally, studies among depressed individuals suggest that peo-
ple who are depressed and/or neurotic tend to have better
cognitive access to past negative events.42
Another difficulty arises when a mixed sample of sympto-
matic and asymptomatic patients is used and then compared
on life events measures. Differences between groups may be
related almost entirely to biased recall amongst the sympto-
matic group and not to the actual experience of life events.
This may explain why 2 of the studies reviewed that used a
mixed patient sample had inconclusive,43 or contradictory26
findings. In a cross-sectional study comparing symptomatic
and asymptomatic UC patients,24 symptomatic participants
were more likely to recall negative life events than asympto-
matic patients. Interestingly, asymptomatic patients with ab-
normal rectal mucosa scored higher on perceived stress than
asymptomatic patients with normal rectal mucosa. Unfortu-
nately, an analysis between these two asymptomatic groups
with respect to life events was not performed—this would have
helped to clarify the role of life events in the inflammation
process, controlling for the experience of symptoms.
In general, the reliability and therefore predictability of
life events measures are low.44 In a study where women were
asked to monitor life events once a month for a 10 month
period and then asked at the end of 10 months to report
again the life events that occurred, only 25% of the events
appeared at both points in time, and the latter list containedsignificantly fewer events.45 This could explain the incon-
clusive findings in one study that asked participants to rate
the amount of stress associated with each life event at the
end of 1 year rather than as the events were occurring.38
Other research has also suggested that retrospective data
greater than 6 months are invalid.46 Finally, without specific
anchors, people tend to have difficulty sticking to a time-
frame when reporting life events. In this sense, an interview
approach47 may yield more accurate information. However,
this technique is time and labor intensive and relies on the
judgment of yet another observer.
All of the studies reviewed assessed life events within the
recommended 6-month time frame, with the average
interval being 10 weeks (range 4 weeks through 24 weeks).
The one study that assessed life events at the 6 month point
used an interview approach to augment reliability.39 This
study also had the longest follow-up (up to 4 years). While it
is better to administer life events questionnaires prospec-
tively, it is very difficult to follow patients over significant
periods of time. However, this would significantly improve
the reliability of data since relapse during that time is more
likely. Two of the studies reviewed39,43 monitored past this 2-
year timeframe.
Finally, it is important to control for (enter as covariates)
other factors thatmay also beprecipitating flare-ups, such as a
change in diet, level of exercise, seasonal variations, smoking
habit, alcohol or non-steroidal anti-inflammatory drug (NSAID)
use.38 There is also considerable symptom overlap between
physical symptoms and markers of depression (reduced ap-
petite, difficulty sleeping, low energy). This may explain the
negative findings in a study looking at the relations between
mood, stress and IBD symptoms reviewed.43
4.5.2. Studies that usedperceived daily hassles asmeasures
of stress
While it has been more popular to look at stress from a life-
events perspective, both for ease of cost and patient burden,
there is some research that suggests the usefulness of daily
stress monitoring and daily symptom monitoring. Inventories
such as the Hassles Questionnaire,48 designed to measure the
cumulative effect of minor stressors, assume that people's
lives are more affected by the accumulation of daily
“hassles” than by the potentially more significant, but less
frequent life events. Research has suggested that hassles and
life events are only moderately correlated and that it is the
hassles that seem to be more closely related to illness.49 This
relation may be mediated less by the daily hassles
themselves as the effects that cumulated stress causes—
increasing health compromising behaviors (smoking, alcohol
consumption, weight gain) or causing negative mood.50
From a statistical analysis perspective, however, linking
daily hassles and disease activity is a very difficult thing to do.
First, it is unclear how quickly “stress” acts on the gastro-
intestinal tract. Therefore, it is difficult to determine wheth-
er we should be focused on the same day/same symptoms
approach, or account for a lag time, or add an accumula-
tion of a week. It is also difficult to account for the effect of
symptoms from the day prior. It is also very burdensome for a
patient to monitor their daily stress for a period of time
necessary to see a flare-up (about 1 year). There is even some
evidence that monitoring of stress itself directly impacts
the monitoring of symptoms.51 The studies reviewed did use
Table 4 Checklist for future studies interested in adding to the stress and IBD research
1. Include multiple measures of stress and mediator variables such as coping, social support and perceived controllability.
2. Avoid using mixed disease groups (CD v. UC) and/or mixed disease status (active v. remission).
3. Choice of participant groups should include a positive and negative control group, such as IBS or another autoimmune diseased
group such as arthritis or MS. A possible negative control group could be colon cancer screening patients, provided they are age
and gender-matched.
4. Make sure your studies are adequately powered.
5. Use objective measures of inflammation and disease activity that include clinical symptoms (i.e. CDAI), markers of the
inflammatory process (i.e. C-reactive protein) and tissue injury (sigmoidoscopy/histology).
6. Avoid cross-sectional designs. These are no longer acceptable.
7. When using prospective designs, avoid comparing patients who flare over time with those who do not as your primary outcome
analyses. Rather multiple regression and logistic regression may better represent your data.
8. Follow-up patients for at least one year to leave adequate time for a flare according to the natural history of the disease.
9. Operationally define stress and identify which framework you are adopting (stressor-based, response-based, cognitive-
transactional), keeping in mind that the Cognitive-Transactional Model of Stress should be considered the “gold-standard.”
10. Include measures of both daily hassles and life events.
11. Always account for the impact of the disease on perceived stress.
12. Where possible, categorize stressors (i.e. interpersonal, financial, occupational) to determine the non-health based stressors
that may be impacting disease.
13. Avoid stress summary scores and dividing patients into “High” or “Low” stress groups based on arbitrary cut-off scores.
14. Account for perception of stress and not the sheer number of occurrences of stressful events.
15. Follow-up intervals should never be less often than every 6 months.
16. Whenever possible, complement self-report of stressors with interviews and timeline anchors.
17. Control for other factors that may be precipitating flares such as smoking, alcohol use, season, etc.
18. When looking at mood variables, recognize the overlap between depression and physical symptoms such as fatigue, loss of
appetite and sleep difficulties.
19. When analyzing data for prospective, daily monitoring studies determine a priori if you would like to look at the data in one of
the following ways: same-day-same symptoms, stress and symptoms accounting for lag time or the effects of symptoms from day
before on stress the following day, or accumulation of weekly stressors.
20. To reduce burden of daily monitoring, consider having participants monitor one week per month for one year instead of daily. Be
sure to still monitor the occurrence of significant life events.
199Stress and IBDstatistically elegant time-series regression,32 pooled time
series,33 or time-series analysis on 20 single cases.52 In this
case, only one of the studies was cross-sectional.27
Theburden of dailymonitoring is likely the largestdrawback
to the study of daily stress on intestinal symptoms. Of the
studies reviewed, the average number of days monitored was
93 (range 28 through 365). One way to reduce the burden of
daily monitoring over a lengthy period of time is to have
patients monitor oneweek out of a month over a year or more,
such as described by Greene and colleagues.33 The main dis-
advantage of this approach is that it is likely tomiss certain key
stressors and their direct impact on key symptoms at any given
time. Related to the problem of daily monitoring is the use of
small samples (hard to get people to participate in these types
of studies). The average number of participants in the studies
reviewed was 13.67, not including the cross-sectional daily
stress study27 which used a considerably larger sample.
Controlling for life events remains important in these types
of studies as well. One must be careful to look for significant
events that may affect the monitoring of daily hassles, not to
mention inflammation linked to life events. One study32 con-
trolled for the effects of life events in their 28-day prospective
study and found that it was the daily stress, rather than life
events that influenced symptoms. Of course, 28 days is a
relatively short amount of time to be examining life events and
the findings may have been different had participants mon-
itored symptoms over a longer period of time. Overall, the
findings in the 4 studies looking at daily stress in IBD suggestedthat daily stress does influence symptoms. One study found
inconclusive results, likely because it was cross-sectional and
used mixed UC and CD patients as well as inactive and active
disease.27 The other 3 studies supported the role of daily stress
in symptoms; one of which offered the caveat that daily stress
affects symptoms for certain patients.52
5. Conclusion
While there is some data and plenty of anecdotal reports of
the effects of stress on IBD disease activity, we continue to
lack a sound paradigm through which to approach this type of
study with more depth and accuracy. With only about half of
the research studies reviewed in the last 15 years suggesting
an association between stress and IBD, and a literature with
significant methodological issues muddying the waters in this
area, we are still unable to draw any conclusions about the
role of stress on inflammation in inflammatory bowel dis-
ease. This review has pointed out some of the reasons why
we are unable to draw strong conclusions in either direction.
See Table 4 for a “checklist” of things to consider in the de-
signing of future studies.
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